Back to search
Glioblastoma Multiforme/Anaplastic Astrocytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Glioblastoma Multiforme/Anaplastic Astrocytoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Glioblastoma Multiforme/Anaplastic Astrocytoma trials you may qualify forA roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
The primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide (…
Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24…
The goal of this study is to determine the efficacy of the 1) ribociclib and everolimus to treat pediatric and young adult patients newly diagnosed with a high-…
Glioblastoma (GBM), WHO grade IV glioma, represents the majority of adult malignant primary brain tumors, with an incidence of 2-3 per 100,000 person-years. The…
Primary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequa…
This phase I trial is studying the side effects and best dose of vorinostat when given together with temozolomide in treating patients with malignant gliomas. D…
This phase II/III trial studies how well vocimagene amiretrorepvec (Toca 511) and extended release flucytosine (Toca FC) work when added to the usual treatment…
This phase II trial studies how well the combination of dabrafenib and trametinib works after radiation therapy in children and young adults with high grade gli…